Recap: 10x Genomics Q4 Earnings

10x Genomics TXG reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

10x Genomics missed estimated earnings by 77.78%, reporting an EPS of $-0.16 versus an estimate of $-0.09.

Revenue was up $31.31 million from the same period last year.

Last quarter the company beat on EPS by $0.05, which was followed by a 11.23% increase in the share price the next day.

Here's a look at 10x Genomics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.20	-0.26	-0.27	-0.23
EPS Actual	-0.15	-0.10	-0.11	-0.08
Revenue Estimate	122.62M	112.85M	102.51M	100.40M
Revenue Actual	125.30M	115.84M	105.82M	112.22M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar